http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103467368-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-61 |
| filingDate | 2013-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103467368-B |
| titleOfInvention | Medical application of N-pyridine methyl/ methoxyl-2-phenoxyl amide |
| abstract | The invention relates to N-pyridine methyl/ methoxyl-2-phenoxyl amide shown as the chemical structural formula I, and an isomer or racemate thereof. In the formula, R1, R2, R3 and R4 are selected from H, C1-C2 alkyl, C3-C4 straight chain or branched alkyl; N is selected from 0 or 1; Y is selected from CH or N; X is selected from fluorine, chlorine, bromine and iodine; X1, X2, X4 and X6 are selected from hydrogen and C1-C2 alkyl; X3 is selected from hydrogen, C1-C2 alkyl, fluorine, chlorine and bromine; and X5 is selected from trifluoromethyl, fluorine, chlorine, bromine or cyano group. An application of the N-pyridine methyl/ methoxyl-2-phenoxyl amide and the isomer or racemate thereof in preparation of anti-cancer drugs is also disclosed. |
| priorityDate | 2013-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.